Novo Nordisk
NVO
$91.79
Share price
0.72%
Change (1 day)
92.67%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Earnings for Novo Nordisk (NVO)
Earnings in 2023 (TTM): $11.43 B
According to Novo Nordisk's latest financial reports the company's current earnings (TTM) are $11.43 B. In 2022 the company made an earning of $9.78 B an increase over its 2021 earnings that were of $9.29 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Novo Nordisk from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $11.43 B | 16.82% |
| 2022 | $9.78 B | 5.35% |
| 2021 | $9.29 B | 12.47% |
| 2020 | $8.26 B | 13.07% |
| 2019 | $7.30 B | -3.35% |
| 2018 | $7.55 B | 1.79% |
| 2017 | $7.42 B | 3.12% |
| 2016 | $7.20 B | 10.9% |
| 2015 | $6.49 B | 8.24% |
| 2014 | $5.99 B | 3.45% |
| 2013 | $5.79 B | 19.02% |
| 2012 | $4.87 B | 15.21% |
| 2011 | $4.22 B | 17.71% |
| 2010 | $3.59 B | 24.78% |
| 2009 | $2.87 B | 16.62% |
| 2008 | $2.46 B | 47.95% |
| 2007 | $1.66 B | 7.07% |
| 2006 | $1.55 B | 18.18% |
| 2005 | $1.31 B | 13.43% |
| 2004 | $1.16 B | |
| 2002 | $0.75 B | -14.39% |
| 2001 | $0.87 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $24.22 B | 111.82% | 🇺🇸 USA |
 Eli Lilly LLY | $7.28 B | -36.33% | 🇺🇸 USA |
 Sanofi SNY | $9.96 B | -12.88% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $8.69 B | -23.94% | 🇺🇸 USA |